Risk factors of fatty liver in obese children
-
摘要:
目的 分析肥胖儿童并发脂肪肝的危险因素。 方法 搜集2014年1月~2016年12月在某三甲医院住院的肥胖儿童,并通过肝脏B超的检测,将肥胖儿童分成单纯肥胖组和肥胖合并脂肪肝组。计算体质量指数和体内平衡模型胰岛素抵抗指数(HOMA-IR)。 结果 共186例患者纳入研究,单纯肥胖组和肥胖合并脂肪肝组均为93例。肥胖合并脂肪肝组的男性比例、年龄、腰围、体质量指数水平比单纯肥胖组高,差异有统计学意义(P<0.05)。年龄、HOMA-IR和尿酸是肥胖儿童发生脂肪肝的危险因素(OR>1,P<0.05)。 结论 男性、大龄、HOMA-IR和尿酸高的肥胖儿童更容易出现脂肪肝。 Abstract:Objective To investigate metabolic differences between simple obese children and those comorbid with fatty liver disease. Methods Obese children hospitalized in our center during 2014-2016 were included and divided into simple obese group and obese with fatty liver group by ultrasound-based diagnosis of fatty liver. Epidemiology data and serum biochemical studies were recorded. Body Mass Index (BMI) and homeostasis model insulin resistance index (HOMA-IR) were calculated. Results A total of 186 obese children were enrolled in this study, including 93 cases of obese children and 93 cases obese patients with fatty liver.The proportion of men and the figure of age, waist circumstance (WC) and BMI were significantly higher in the group of obese patients with fatty liver (P<0.05). Age and UA were found to be risk factors for fatty liver disease (OR>1,P<0.05). Conclusion Male, older children or children with higher uric acid are more susceptible to fatty liver among obese children. -
Key words:
- children /
- obesity /
- fatty liver disease /
- risk factors
-
表 1 两组患者的一般情况和代谢特点比较(n=93)
因素 单纯肥胖组 肥胖合并脂肪肝组 P 性别[男,n(%)] 54(58%) 73(78%) 0.003 年龄(岁) 9(1, 16) 12(7, 16) 0.000 BMI(kg/m2) 25.5±3.4 28.1±3.7 0.000 腰围(cm) 83.5±11.5 92.0±9.9 0.000 BMI: 体质量指数. 表 2 肥胖儿童脂肪肝危险因素分析
因素 B S.E. Wald P OR 95%CI 性别 0.525 0.391 1.803 0.179 1.691 0.786~3.640 年龄 0.201 0.091 4.818 0.028 1.222 1.022~1.462 BMI 0.065 0.087 0.568 0.451 1.067 0.901~1.265 腰围 0.000 0.031 0.000 0.992 1.000 0.940~1.063 HOMA-IR 0.105 0.054 3.811 0.050 1.111 1.000~1.234 甘油三酯 0.165 0.385 0.183 0.668 1.179 0.554~2.510 总胆固醇 -0.468 0.546 0.735 0.391 0.626 0.215~1.825 HDL-C 1.191 0.793 2.258 0.133 3.290 0.696~15.554 LDL-C 0.369 0.595 0.385 0.535 1.446 0.451~4.640 尿酸 0.004 0.002 4.131 0.042 1.004 1.000~1.008 BMI: 体质量指数; HOMA-IR: 体内平衡模型胰岛素抵抗指数; HDL-C: 高密度脂蛋白胆固醇; LDL-C: 低密度脂蛋白胆固醇. -
[1] Wang S, Dong YH, Wang ZH, et al. Trends in overweight and obesity among Chinese children of 7-18 years old during 1985-2014[J]. Chin J Prevent Med, 2017,51(4): 300-5. [2] Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J]. J Gastroenterol Hepatol, 2013, 28(1, SI): 11-7. [3] Meng L, Luo N, Mi J. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children[J]. Biomed Environment Scien, 2011, 24(1): 22-30. [4] 李华, 肖延风, 尹春燕, 等. 单纯性肥胖儿童脂肪肝相关危险因素分析[J]. 中国妇幼健康研究, 2017, 16(04): 366-8. doi: 10.3969/j.issn.1673-5293.2017.04.002 [5] 冯海霞, 万燕萍, 周一泉, 等. 儿童单纯性肥胖相关危险因素的性别差异[J]. 中华实用儿科临床杂志, 2014, 29(19): 1471-5. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_syeklczz201419009 [6] Cole TJ, Lobstein T. Body mass index cut-offs for thinness,overweight and obesity[J]. Pediatr Obes, 2012, 7(4): 284-94. doi: 10.1111/ijpo.2012.7.issue-4 [7] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J]. Gastroenterology, 2012, 142(7): 1592-609. doi: 10.1053/j.gastro.2012.04.001 [8] Xu C, Yu C, Ma H,et al. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population:the Zhejiang Zhenhai Study[J]. Am J Gastroenterol , 2013, 108(8): 1299-304. doi: 10.1038/ajg.2013.104 [9] Alkassabany YM, Farghaly AG, El-Ghitany EM. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt[J]. Arab J Gastroenterol, 2014, 15(2): 76-81. doi: 10.1016/j.ajg.2014.05.002 [10] Zhang HX, Xu XQ, Fu JF, et al. Predicting hepatic steatosis and liver fat content in obese children based on biochemical parameters and anthropometry[J]. Pediatr Obes, 2015, 10(2): 112-7. doi: 10.1111/ijpo.2015.10.issue-2 [11] Awai HI, Newton KP, Sirlin CB,et al. Evidence and recommendations for imaging liver fat in children. Based on systematic review[J]. Clin Gastroenterol Hepatol, 2014, 12(5): 765-73. doi: 10.1016/j.cgh.2013.09.050 [12] 刘燕妮, 张知新. 儿童非酒精性脂肪肝发病机制研究进展[J]. 中日友好医院学报, 2015,18(04): 257-9. doi: 10.3969/j.issn.1001-0025.2015.04.020 [13] Rinella ME. Nonalcoholic fatty liver disease:a systematic review[J]. JAMA, 2015, 314(14): 2263-73. [14] Zhang H, Yang H, Lai C, et al. Quantitative relationship between liver fat content and metabolic syndrome in obese children and adolescents[J]. Clin Endocrinol (Oxf), 2015, 83(1): 43-9. doi: 10.1111/cen.2015.83.issue-1 [15] 胡伟, 尹春燕, 肖延风. 代谢异常在单纯性肥胖儿童脂肪肝中的作用[J]. 中国妇幼健康研究, 2015,16(02): 191-3. doi: 10.3969/j.issn.1673-5293.2015.02.008 [16] 康如彤, 钟燕, 蒋耀辉, 等. 肥胖儿童非酒精性脂肪肝影响因素分析[J]. 实用预防医学, 2013, 20(03): 277-9. doi: 10.3969/j.issn.1006-3110.2013.03.007 [17] Bonakdaran S, Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes[J]. Curr Diabetes Rev, 2014, 10(2): 113-7. doi: 10.2174/1573399810666140228160938 [18] Choi YJ, Shin HS, Choi HS, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J]. Lab Invest, 2014, 94(10): 1114-25. doi: 10.1038/labinvest.2014.98 [19] Chernyak OO, Sentsova TB, Vorozhko IV, et al. Genomic, proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients[J]. Voprosy Pitan,2015, 84(4): 18-24. [20] Li M, Zhang S, Wu Y, et al. Prevalence of insulin resistance in subjects with nonalcoholic fatty liver disease and its predictors in a Chinese population[J]. Dig Dis Sci, 2015, 60(7): 2170-6. doi: 10.1007/s10620-015-3564-5 [21] Dixon JB, Bhathal PS, O'brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese[J]. Gastroenterology, 2001, 121(1): 91-100. doi: 10.1053/gast.2001.25540 [22] Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease[J]. Atherosclerosis, 2015, 239(1): 192-202. doi: 10.1016/j.atherosclerosis.2015.01.001 [23] Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome[J]. Lancet Diab Endocrinol, 2014, 2(11): 901-10. doi: 10.1016/S2213-8587(14)70032-4 [24] 刘瑞侠, 黄有烨, 胡红琳. 肥胖症非酒精性脂肪肝病的发病机制研究进展[J]. 安徽医学, 2017,32(04): 512-6. doi: 10.3969/j.issn.1000-0399.2017.04.038 [25] Cai W, Song JM, Zhang B, et al. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population[J]. Scien World J, 2014,22(7): 393628-35.
点击查看大图
表(2)
计量
- 文章访问数: 791
- HTML全文浏览量: 286
- PDF下载量: 3
- 被引次数: 0